V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007001 | 330003780 | 1.04 | 80.6 | Curative (C) | 2017-12-05 | 2017-12-22 | Cisplatin 7 day | N | N | 330007315 | CISPLATIN |
| 330007002 | 330003782 | 1.64 | 61.8 | Neo-adjuvant (N) | 2014-10-26 | 2014-12-10 | EW EuroEwing 2012 Arm A VAI | N | null | 330007321 | TRIAL |
| 330007003 | 330003782 | 0 | null | Curative (C) | 2013-06-14 | 2014-01-02 | Trial Unspecified | N | N | 330007321 | TRIAL |
| 330007004 | 330003784 | null | null | Palliative (P) | 2018-08-09 | 2018-08-30 | Trial Unspecified | N | N | 330007328 | TRIAL |
| 330007005 | 330003784 | 1.84 | 92 | Palliative (P) | 2017-03-26 | 2017-05-07 | Cisplatin 7 day | N | N | 330007328 | CISPLATIN |
| 330007006 | 330003785 | null | 63.9 | Curative (C) | 2013-11-23 | 2013-11-23 | MIFAMURTIDE | null | N | 330007345 | MIFAMURTIDE |
| 330007007 | 330010362 | 1.73 | 80 | Curative (C) | 2014-10-06 | 2014-10-06 | Trial Unspecified | 02 | N | 330007345 | TRIAL |
| 330007008 | 330003787 | 1.66 | 71 | Curative (C) | 2016-01-13 | 2016-02-09 | METHOTREXATE | N | N | 330007347 | METHOTREXATE |
| 330007009 | 330008045 | 1.72 | 70 | Curative (C) | 2015-08-14 | 2015-08-14 | METHOTREXATE | null | N | 330007347 | METHOTREXATE |
| 330007010 | 330003790 | 1.71 | null | Neo-adjuvant (N) | 2015-07-19 | 2015-08-07 | METHOTREXATE | N | N | 330007357 | METHOTREXATE |
| 330007011 | 330008048 | 1.7 | 63.6 | Curative (C) | null | 2014-05-15 | METHOTREXATE | N | null | 330007358 | METHOTREXATE |
| 330007012 | 330010365 | 1.8 | 97.9 | Neo-adjuvant (N) | 2014-07-04 | 2014-07-11 | OST Mifamurtide | Y | Y | 330007359 | MIFAMURTIDE |
| 330007013 | 330003794 | 1.6 | 77.2 | Curative (C) | null | 2016-11-15 | METHOTREXATE | 02 | Y | 330007368 | METHOTREXATE |
| 330007014 | 330003795 | 0 | 47.6 | Curative (C) | 2017-11-29 | 2017-12-03 | MIFAMURTIDE | 2 | N | 330007378 | MIFAMURTIDE |
| 330007015 | 330003798 | 1.92 | 17.1 | Palliative (P) | 2015-05-21 | 2016-03-07 | METHOTREXATE | N | N | 330007381 | METHOTREXATE |
| 330007016 | 330003799 | 1.76 | 84.4 | Adjuvant (A) | null | 2016-11-25 | METHOTREXATE | Y | null | 330007382 | METHOTREXATE |
| 330007017 | 330008053 | 1.7 | 63.4 | Adjuvant (A) | 2016-06-11 | 2016-06-14 | OST Euramos 1 Closed Trial - A | N | N | 330007388 | DOXORUBICIN |
| 330007018 | 330008054 | 1.46 | 70.4 | null | 2013-09-12 | 2015-04-21 | DOXORUBICIN | 01 | N | 330007390 | DOXORUBICIN |
| 330007019 | 330008055 | 1.75 | 98.4 | Disease modification (D) | 2016-05-08 | 2016-05-12 | Trial Unspecified | 2 | N | 330007390 | TRIAL |
| 330007020 | 330003804 | 1.78 | 63.6 | Curative (C) | null | 2018-02-06 | Trial Unspecified | N | N | 330007412 | TRIAL |
| 330007021 | 330003806 | 1.72 | 68.5 | Curative (C) | 2014-03-15 | 2014-04-09 | Cisplatin 7 day | null | null | 330007412 | CISPLATIN |
| 330007022 | 330003807 | 1.75 | 115 | Palliative (P) | 2013-04-30 | 2013-05-18 | EW EuroEwing 2012 Arm A VAI | N | N | 330007417 | TRIAL |
| 330007023 | 330003808 | 1.61 | 84.5 | Adjuvant (A) | 2017-10-18 | 2017-10-30 | OST Mifamurtide | N | Y | 330007417 | MIFAMURTIDE |
| 330007024 | 330003809 | 0 | 0 | Curative (C) | null | 2014-06-25 | METHOTREXATE | 02 | N | 330007427 | METHOTREXATE |
| 330007025 | 330003810 | 1.78 | 82.7 | Palliative (P) | 2017-04-18 | 2017-04-19 | Trial Unspecified | Y | N | 330007427 | TRIAL |
| 330007026 | 330003810 | null | 86.95 | Curative (C) | 2015-06-01 | 2015-06-25 | Trial Unspecified | N | N | 330007427 | TRIAL |
| 330007027 | 330003810 | 1.58 | 55 | Curative (C) | 2014-11-04 | 2014-12-29 | Cisplatin | null | N | 330007427 | CISPLATIN |
| 330007028 | 330003811 | 1.9 | null | Curative (C) | 2015-04-26 | 2015-12-07 | METHOTREXATE | N | N | 330007437 | METHOTREXATE |
| 330007029 | 330003811 | 0 | 71 | Neo-adjuvant (N) | 2015-10-12 | 2015-12-24 | Cisplatin 7 day | N | Y | 330007437 | CISPLATIN |
| 330007030 | 330003811 | null | 88.2 | Adjuvant (A) | 2013-01-06 | 2013-07-06 | Mifamurtide weeks 13-36 | N | N | 330007437 | MIFAMURTIDE |
| 330007031 | 330003811 | 1.6 | 18 | Adjuvant (A) | 2018-02-14 | 2018-02-16 | MIFAMURTIDE | Y | N | 330007437 | MIFAMURTIDE |
| 330007032 | 330003812 | 1.72 | 83.55 | null | 2016-10-30 | 2016-10-30 | DOXORUBICIN | N | N | 330007452 | DOXORUBICIN |
| 330007033 | 330003815 | 0 | 82.1 | Curative (C) | 2016-05-07 | 2016-12-08 | Mifamurtide weeks 1-12 | 02 | N | 330007452 | MIFAMURTIDE |
| 330007034 | 330003816 | 1.45 | 41.8 | Curative (C) | 2016-02-08 | 2016-05-01 | Trial Unspecified | N | N | 330007467 | TRIAL |
| 330007035 | 330003818 | 1.74 | 94 | Palliative (P) | 2017-11-16 | 2017-11-16 | EW EuroEwing 2012 Arm B IE | N | N | 330007472 | TRIAL |
| 330007036 | 330003818 | 1.51 | null | Curative (C) | 2014-12-12 | 2014-12-24 | Trial Unspecified | Y | Y | 330007472 | TRIAL |
| 330007037 | 330003820 | 1.7 | 25.6 | Curative (C) | 2014-09-19 | 2015-04-18 | OST Mifamurtide | N | N | 330007479 | MIFAMURTIDE |
| 330007038 | 330003823 | 0 | 63 | Adjuvant (A) | 2013-01-27 | 2013-08-13 | MIFAMURTIDE | Y | N | 330007480 | MIFAMURTIDE |
| 330007039 | 330008068 | 1.67 | 56.8 | Neo-adjuvant (N) | null | 2014-09-15 | METHOTREXATE | Y | null | 330007485 | METHOTREXATE |
| 330007040 | 330003826 | 1.77 | 72.5 | Adjuvant (A) | 2013-03-09 | 2013-07-27 | METHOTREXATE | N | N | 330007486 | METHOTREXATE |
| 330007041 | 330003828 | 1.58 | 88.9 | Palliative (P) | 2018-02-25 | 2018-02-28 | DOXORUBICIN | N | N | 330007486 | DOXORUBICIN |
| 330007042 | 330010379 | 1.71 | 81.5 | Palliative (P) | 2013-09-08 | 2013-09-29 | Trial Unspecified | N | N | 330007490 | TRIAL |
| 330007043 | 330003829 | 1.32 | 52 | null | null | 2015-09-15 | DOXORUBICIN | N | null | 330007491 | DOXORUBICIN |
| 330007044 | 330003829 | null | 54 | Curative (C) | null | 2017-02-17 | Mifamurtide weeks 1-12 | N | null | 330007491 | MIFAMURTIDE |
| 330007045 | 330003831 | null | 53 | Curative (C) | 2015-07-05 | 2016-03-08 | Trial Unspecified | N | null | 330007505 | TRIAL |
| 330007046 | 330003832 | null | 17.6 | Palliative (P) | 2014-10-04 | 2014-10-04 | Trial Unspecified | null | null | 330007510 | TRIAL |
| 330007047 | 330008074 | 0 | 77.2 | Curative (C) | 2014-01-14 | 2014-07-08 | DOXORUBICIN | N | N | 330007518 | DOXORUBICIN |
| 330007048 | 330003833 | 1.8 | 43.2 | Curative (C) | 2014-10-15 | 2015-03-11 | METHOTREXATE | N | N | 330007519 | METHOTREXATE |
| 330007049 | 330003835 | 1.79 | 63.9 | null | null | 2015-12-08 | Mifamurtide weeks 1-12 | null | null | 330007522 | MIFAMURTIDE |
| 330007050 | 330003835 | 1.61 | 45.3 | Curative (C) | null | 2018-02-17 | METHOTREXATE | N | N | 330007522 | METHOTREXATE |